Benfotiamine information from DrugsUpdate
Benfotiamine (rINN, or S-benzoylthiamine O-monophoshate) is a synthetic S-acyl derivative of thiamine (vitamine B1). After absorption, benfotiamine can be dephosphorylated by cells bearing an ecto-alkaline phosphatase to the lipid-soluble S-benzoylthiamine. Benfotiamine should not be confused with allithiamine, a naturally occurring thiamine disulfide derivative with a distinct pharmacological profile.
Pharmacodynamics
Pharmacokinetics
Benfotiamine is an allithiamine that boosts Advanced Glycation Endproduct (AGE)-inhibiting thiamine pyrophosphate and cell-shielding transketolase activity.
Benfotiamine Indications / Benfotiamine Uses
Information Not Available
Benfotiamine Adverse Reactions / Benfotiamine Side Effects
Information Not Available
Precautions
Information Not Available
Special Precautions
Information Not Available
Other Drug Interactions
Information Not Available
Other Interactions
Information Not Available
Dosage
Oral Diabetic neuropathy, Alcoholic neuropathy Adult: 100 mg 4 times daily.
Food(before/after)
Information Not Available
List of Contraindications
Benfotiamine and Pregnancy
Information Not Available
Benfotiamine and Lactation
Information Not Available
Benfotiamine and Children
Information Not Available
Benfotiamine and Geriatic
Information Not Available
Benfotiamine and Other Contraindications
Hypersentivity
Storage
Information Not Available
Lab interference
Information Not Available
FOLLOW US:
